Article 57 product data
Submitted by Anonymous (not verified) on 13 January 2026 - 11:00
Article 57 product data
Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) multistakeholder workshop on Patient Registries for Alzheimer's disease, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 December 2025, 09:00 (CET) t
Submitted by Anonymous (not verified) on 13 January 2026 - 10:10
Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) multistakeholder workshop on Patient Registries for Alzheimer's disease, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 December 2025, 09:00 (CET) to 15 December 2025, 17:30 (CET)
EMA/PE/0000232896
Submitted by Anonymous (not verified) on 12 January 2026 - 16:28
EMA/PE/0000232896
EMEA-000976-PIP01-10
Submitted by Anonymous (not verified) on 12 January 2026 - 16:27
EMEA-000976-PIP01-10
Opinion/decision on a Paediatric investigation plan (PIP): Zeposia, Ozanimod (hydrochloride), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0131/2022
Submitted by Anonymous (not verified) on 12 January 2026 - 16:26
Opinion/decision on a Paediatric investigation plan (PIP): Zeposia, Ozanimod (hydrochloride), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0131/2022
Human medicines European public assessment report (EPAR): Celsentri, maraviroc, Date of authorisation: 18/09/2007, Revision: 32, Status: Authorised
Submitted by Anonymous (not verified) on 12 January 2026 - 16:25
Human medicines European public assessment report (EPAR): Celsentri, maraviroc, Date of authorisation: 18/09/2007, Revision: 32, Status: Authorised
Agenda of the CVMP meeting 13-15 January 2026
Submitted by Anonymous (not verified) on 12 January 2026 - 15:34
Agenda of the CVMP meeting 13-15 January 2026
Pharmacovigilance Risk Assessment Committee (PRAC): 12 - 15 January 2026, European Medicines Agency, Amsterdam, the Netherlands, from 12 January 2026 to 15 January 2026
Submitted by Anonymous (not verified) on 12 January 2026 - 15:15
Pharmacovigilance Risk Assessment Committee (PRAC): 12 - 15 January 2026, European Medicines Agency, Amsterdam, the Netherlands, from 12 January 2026 to 15 January 2026
Agenda of the PRAC meeting 12 - 15 January 2026
Submitted by Anonymous (not verified) on 12 January 2026 - 15:12
Agenda of the PRAC meeting 12 - 15 January 2026
Q&A clinic on Substance, Organisation, Referentials Management Services, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 December 2025, 11:00 (CET) to 15 December 2025, 12:00 (CET)
Submitted by Anonymous (not verified) on 12 January 2026 - 15:03
Q&A clinic on Substance, Organisation, Referentials Management Services, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 December 2025, 11:00 (CET) to 15 December 2025, 12:00 (CET)